Two executives of Porton Pharma Solutions (300363.SZ) plan to spend between 0.6 million yuan and 1 million yuan to increase their shareholdings.

Porton Pharma Solutions (300363.SZ) announced that Chen Hui, deputy general manager and financial officer of the company, and the deputy general manager and director...

Zhitong FinanceJul 10 07:55 ET

Porton Pharma Solutions Ltd.'s (SZSE:300363) Stock Price Dropped 9.3% Last Week; Retail Investors Would Not Be Happy

Key Insights Porton Pharma Solutions' significant retail investors ownership suggests that the key decisions are influenced by shareholders from the larger public A total of 8 investors have a major

Simply Wall StJun 30 20:39 ET

Boteng Co., Ltd. (300363.SZ): 2023 equity distribution, 10 distributions of 4.87 yuan, share registration date May 28

On May 22, Ge Longhui Co., Ltd. (300363.SZ) announced that the company's 2023 equity distribution plan is to distribute RMB 4.870,000 in cash (tax included) to all shareholders for every 10 shares based on the company's current total share capital excluding the 3,282,344 shares that have already been repurchased. The share registration date for this equity distribution is May 28, 2024, and the ex-dividend date is May 29, 2024.

Gelonghui FinanceMay 22 04:59 ET

Boteng Co., Ltd. (300363.SZ): Can provide CDMO services for different types of drugs and therapies such as small molecule drugs, large molecule drugs, and gene cell therapy

Gelonghui, May 10 | Boteng Co., Ltd. (300363.SZ) said on the investor interactive platform that the company is a pharmaceutical R&D and production outsourcing organization (CDMO) that provides full-category, end-to-end services for pharmaceutical companies, biotechnology companies, scientific research institutions, etc. on a global scale, and can provide CDMO services for different types of drugs and therapies such as small molecule drugs, large molecule drugs, and gene cell therapy. The company continues to invest in R&D resources to establish an interdisciplinary innovative technology platform covering drug crystallization, biocatalysis, fluid chemistry, micronized powders, highly active drugs, preparation chromatography, fluorine chemistry, photochemistry,

Gelonghui FinanceMay 10 05:01 ET

Zhitong A Share Sale Restriction and Release List | May 10

According to the Zhitong Finance App, the ban on restricted shares of 13 listed companies was lifted on May 10, with a total market value of about 28.01 billion yuan. Today's specific restricted shares are as follows: Stock abbreviation, stock code, restricted share type, number of unbanned shares: Xiamen Cinda 000701 shares, original shareholders placed 120 million, Cangzhou Dahua 600230, share incentives, 2.142,400, share incentives, restricted circulation 20375 million, Jinfu Technology 300128 additional A-shares, corporate placement and listing of 205 million yuan Dazhong Mining 001203 shares before issuance

Zhitong FinanceMay 9 21:00 ET

Boteng Co., Ltd. (300363.SZ) announced first-quarter results, with a net loss of 94.8708 million yuan, a year-on-year profit to loss

Boteng Co., Ltd. (300363.SZ) released its report for the first quarter of 2024, and the company achieved revenue during the reporting period...

Zhitong FinanceApr 26 12:17 ET